Search
Search Results
-
Long-term adjuvant chemotherapy after resection for pancreatic cancer patients with positive peritoneal lavage cytology
PurposeThe significance of resection for pancreatic cancer with positive peritoneal lavage cytology (CY +) remains controversial, and the lack of...
-
Fear of Cancer Recurrence in peritoneal malignancy patients following treatment: a cross-sectional study
PurposeTo assess Fear of Cancer Recurrence (FCR)—its prevalence, trajectory, and relationship to several demographic and clinical characteristics,...
-
Single-cell RNA sequencing reveals the lineage of malignant epithelial cells and upregulation of TAGLN2 promotes peritoneal metastasis in gastric cancer
BackgroundPeritoneal metastasis (PM) is an important factor contributing to poor prognosis in patients with gastric cancer (GC). Transcriptomic...
-
Clinical Impact of Radical Resection of Synchronous and Metachronous Peritoneal Metastases from Colorectal Cancer
BackgroundAccording to some case series, patients with colorectal cancer (CRC) who underwent radical resection of synchronous peritoneal metastases...
-
Expression and significance of SIRT6 in human peritoneal dialysis effluents and peritoneal mesothelial cells
Sirtuin 6 (SIRT6) can inhibit the fibrosis of many organs. However, the relationship between SIRT6 and peritoneal fibrosis (PF) in peritoneal...
-
BMSC-derived Exosomes Ameliorate Peritoneal Dialysis-associated Peritoneal Fibrosis via the Mir-27a-3p/TP53 Pathway
ObjectivePeritoneal fibrosis (PF) is the main cause of declining efficiency and ultrafiltration failure of the peritoneum, which restricts the...
-
Personalized analysis of minimal residual cancer cells in peritoneal lavage fluid predicts peritoneal dissemination of gastric cancer
Peritoneal dissemination (PD) is a major type of gastric cancer (GC) recurrence and leads to rapid death. Current approaches cannot precisely...
-
Removal of small extracellular vesicles inhibits the progression of peritoneal dissemination in gastric cancer
BackgroundThe prognosis of gastric cancer patients with peritoneal dissemination is extremely poor and effective treatment for peritoneal...
-
Predictive performance of radiomics for peritoneal metastasis in patients with gastric cancer: a meta-analysis and radiomics quality assessment
PurposeThe purpose of this meta-analysis is to systematically review the diagnostic performance of radiomic techniques in predicting peritoneal...
-
Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal metastasis of colorectal cancer: long-term follow-up results at a single institution in Korea
PurposeThis study aimed to examine the 7-year follow-up results of cytoreductive surgery (CRS) and intraperitoneal chemotherapy (IPC) for peritoneal...
-
A novel risk model for predicting peritoneal metastasis in colorectal cancer based on the SEER database
BackgroundEarly detection and intervention could significantly improve the prognosis of patients with peritoneal metastasis (PM). Our main purpose...
-
Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface Malignancies
Malignancies of the peritoneal cavity are associated with a dismal prognosis. Systemic chemotherapy is the gold standard for patients with...
-
Peritoneal Cell-Free Tumor DNA is a Biomarker of Locoregional and Peritoneal Recurrence in Resected Pancreatic Ductal Adenocarcinomas
BackgroundRecurrence after curative-intent pancreatectomy for pancreatic ductal adenocarcinomas (PDAC) is quite frequent with locoregional and...
-
Ileal perforation at the site of peritoneal metastasis with intestinal infiltration by dual EGFR-VEGF pathway inhibition in an EGFR-mutant non-small cell lung cancer patient
Gastrointestinal (GI) perforation including ileal perforation is a rare complication of antivascular endothelial growth factor (anti-VEGF) therapy....
-
Early Cost-Effectiveness Analysis of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer Patients with Limited Peritoneal Carcinomatosis
BackgroundGastric cancer patients with peritoneal carcinomatosis (PC) have a poor prognosis, with a median overall survival of 10 months when treated...
-
Optimal peritoneal cancer index cutoff point for predicting surgical resectability of pseudomyxoma peritonei in treatment-naive patients
BackgroundThe peritoneal cancer index (PCI) has been used to predict surgical outcomes for pseudomyxoma peritonei (PMP). The present study aimed to...
-
Poorly Differentiated Lung Cancer with Intracardiac Extension Causing Malignant Stroke in a Peritoneal Dialysis Patient: a Case Report
Cardiac involvement occurs in an almost one quarter of all the patients with lung cancer. Lymphatogenous spread is a more common route of tumor...
-
Comparison of the risks of renal cell carcinoma or urothelial cancer between hemodialysis and peritoneal dialysis patients
PurposeThis study is to compare risks of develo** renal cell carcinoma or urothelial cancer between hemodialysis (HD) and peritoneal dialysis (PD)...
-
Utilizing Patient-Derived Organoids in the Management of Colorectal Cancer with Peritoneal Metastases: A Review of Current Literature
IntroductionTreatment of colorectal cancer-derived peritoneal carcinomatosis (CRC-PC) is challenging due to cellular heterogeneity that exhibits...
-
Limitations of laparoscopy to assess the peritoneal cancer index and eligibility for cytoreductive surgery with HIPEC in peritoneal metastasis
PurposeWe aimed to determine the value of laparoscopy to assess the intra-abdominal tumor extent and predict complete cytoreduction.
Methods ...